About CLINUVEL

'Check up' reports on rare disease EPP and SCENESSE® (afamelanotide)

27 Feb 2012

On 31 January 2012 Swiss TV channel Telezueri aired a report on erythropoietic protoporphyria (EPP), a rare genetic disorder which causes absolute intolerance of skin to sunlight, and CLINUVEL’s novel drug SCENESSE® (afamelanotide), which has been trialed as a photoprotective in EPP. CLINUVEL has subtitled the 'Check up' program and re-released for the broader EPP community.
All footage and soundtrack are copyright © Telezueri 2012.

Quick Links